内科学-心律失常-课件.ppt
- 【下载声明】
1. 本站全部试题类文档,若标题没写含答案,则无答案;标题注明含答案的文档,主观题也可能无答案。请谨慎下单,一旦售出,不予退换。
2. 本站全部PPT文档均不含视频和音频,PPT中出现的音频或视频标识(或文字)仅表示流程,实际无音频或视频文件。请谨慎下单,一旦售出,不予退换。
3. 本页资料《内科学-心律失常-课件.ppt》由用户(ziliao2023)主动上传,其收益全归该用户。163文库仅提供信息存储空间,仅对该用户上传内容的表现方式做保护处理,对上传内容本身不做任何修改或编辑。 若此文所含内容侵犯了您的版权或隐私,请立即通知163文库(点击联系客服),我们立即给予删除!
4. 请根据预览情况,自愿下载本文。本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
5. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007及以上版本和PDF阅读器,压缩文件请下载最新的WinRAR软件解压。
- 配套讲稿:
如PPT文件的首页显示word图标,表示该PPT已包含配套word讲稿。双击word图标可打开word文档。
- 特殊限制:
部分文档作品中含有的国旗、国徽等图片,仅作为作品整体效果示例展示,禁止商用。设计者仅对作品中独创性部分享有著作权。
- 关 键 词:
- 内科学 心律失常 课件
- 资源描述:
-
1、 ArrhythmiaConduction and anatomy of heartConduction systemStable SVT is generally well tolerated in patients without underlying heart disease!?but may lead to myocardial ischemia or congestive heart failure in patients with coronary disease,valvular abnormalities,and systolic or diastolic myocardia
2、l dysfunction.Ventricular tachycardia,if lasting 1030 secs,often results in hemodynamic compromise and is more likely to deteriorate into ventricular fibrillation.RATE&RHYTHMRATE&RHYTHMAslow heart rates produce symptoms Aat rest or on exertion depends upon whether cerebral perfusion can be maintaine
3、d,which is generally a function of whether the patient is upright or supine and whether left ventricular function is adequate to maintain stroke volume.A If the heart rate abruptly slows,as with the onset of complete heart block or sinus arrest,syncope or convulsions may result.RATE&RHYTHM4Arrhythmi
4、as are detected either because they present with symptoms or detected during the course of monitoring.4Arrhythmias causing sudden death,syncope,or near syncope require further evaluation and treatment unless they unlikely to recur (eg,electrolyte abnormalities or acute myocardial infarction).4Contro
5、versy over when and how to evaluate and treat rhythm disturbances that are not symptomatic but are possible markers for more serious abnormalities(eg,nonsustained ventricular tachycardia).MECHANISMS OF ARRHYTHMIASuElectrophysiologic studies have greatly increased our understanding of the mechanisms
6、underlying most arrhythmias.These includeu(1)disorders of impulse formation or automaticityu(2)abnormalities of impulse conduction,u(3)reentry,and u(4)triggered activity.uAltered automaticity is the mechanism for sinus node arrest,many premature beats,and automatic rhythms as well as an initiating f
7、actor in reentry,arrhythmias.MECHANISMS OF ARRHYTHMIASAbnormalities of impulse conduction can occur at the sinus or atrioventricular node,in the intraventricular conduction system,and within the atria or ventricles.These are responsible for sinoatrial exit block,for atrioventricular block at the nod
8、e or below,and for establishing reentry circuits.MECHANISMS OF ARRHYTHMIASMECHANISMS OF ARRHYTHMIAS Triggered activity occurs when afterdepolarizations(abnormal electrical activity persisting after repelarization)reach the threshold level required to trigger a new depolarization.This may be the mech
9、anism of ventricular tachycardia in the prolonged QT syndrome and in some cases of digitalis toxicity.TECHNIQUES FOR EVALUATING RHYTHM DISTURBANCESElectrocardiographic MonitoringThe ideal way of establishin,g a causal relationship between a symptom and a rhythm disturbance is to demonstrate the pres
10、ence of the rhythm during the symptom,Unfortunately,this is not always easy because symptoms are usually sporadic.TECHNIQUES FOR EVALUATING RHYTHM DISTURBANCESElectrocardiographic MonitoringPatients with SD and recent or recurrent syncope are often monitored.Outpatients.When episodes are infrequent,
11、use of an event recorder is preferable to 24-hour continuous monitoring.Exercise testing may be helpful when the symptoms are associated with exertion or stress.Further electrophysielogic studies may be useful in evaluating ventricular tachyarrhythmias.TECHNIQUES FOR EVALUATING RHYTHM DISTURBANCES4E
12、lectrocardiographic MonitoringElectrocardiographic MonitoringElectrocardiographic MonitoringTECHNIQUES FOR EVALUATING RHYTHM DISTURBANCESECG MonitoringlIn many cases,symptoms are due to a different arrhythmia or to noncardiac causes.lFor instance,dizziness or syncope in older patients may be unrelat
13、ed to concomitantly observed bradycardia,sinus node abnormalities,and ventricular ectopy.lAmbulatory monitoring is frequently used to quantify ventricular ectopy and detect asymptomatic ventricular tachycardia in post-myocardial infarction or heart failure patients.lUnfortunately,while asymptomatic
14、ventricular arrhythmias have negative prognostic implications,there are few-data to support specific therapeutic intervention.Thus,monitoring in asymptomatic individuals is usually not indicated.TECHNIQUES FOR EVALUATING RHYTHM DISTURBANCESHeart rate Variablityseveral studies have indicated that gre
15、ater heart rate variability is associaled with a better prognosis and fewer life threatening arrhythmias in a variety of cardiac conditions.RR cycle length variability to provide indices of the relative balance between parasympathetic and sympathetic activity,with being considered to confer a better
16、 prognosis.postinfarction and patients with symptomatic arrhythmias,these Indices have had some prognostic value.However,adequate data are not yet available to support routine use of this technique in clinical practice.TECHNIQUES FOR EVALUATING RHYTHM DISTURBANCESSignal-Averaged ECG4Signal averaged
17、ECG is new technique.4To record 300 consecutive beats during basal conditions,Using appropriate electrical filtering and computer averaging of the signal,very law frequency signals called late potentials can be identified in the period following the QRS complex.4Abnormal late potentials are consider
18、ed markers for potential Ventricular ArrhythmiaTECHNIQUES FOR EVALUATING RHYTHM DISTURBANCES Evaluation of recurrent syncope of possible cardiac origin,when the ambulatory ECG has not provided the diagnosis;Differentiation of SVT from VA;Evaluation of therapy in patients with accessory atrioventricu
19、lar pathways;Evaluation of the efficacy of pharmacotherapy in survivors of sudden death or other patients with symptomatic or life threatening VT;Evaluation of patients for catheter ablation procedures or antitachycardia devices.Autonomic Testing(Tilt Table Testing)with recurrent syncope or near Syn
20、cope,arrhythmias are no cause.This is particularly true when the patient has no evidence of associated heart disease by history,examination,ECG,or noninvasive testing.Syncope may be neurocardiogenic in origin,mediated by excessive vagal stimulation or an imbalance between sympathetic and parasympath
21、etic autonomic activity.TECHNIQUES FOR EVALUATING RHYTHM DISTURBANCESTECHNIQUES FOR EVALUATING RHYTHM DISTURBANCES4Autonomic Testing(Tilt Table Testing)60-80TECHNIQUES FOR EVALUATING RHYTHM DISTURBANCESAntiarrhythmia drugMAntiarrhythmic drugs have limited efficacy and frequent side effects.They are
22、often divided into four classes.MClass I agents block membrane sodium channels.Three subclasses are further defined by the effect of agents on the Purkinje fiber action potential MClass la drugs slow the rate of rise of the action potential(Vmax)and prolong its duration,thus slowing conduction and i
23、ncreasing refractorineas.MClass lb agents shorten action potential duration,they do not affect conduction or refractoriness.MClass Ic agents prolong Vmax and slow repolarization,thus slowing conduction and prolonging refractoriness,but more so than class la drugsAntiarrhythmia drug4Class II agents-b
24、eta-blockers Decrease automaticity,Prolong AV conduction,Prolong refractoriness.Antiarrhythmia drugClass III agents ABlock potassium channels AProlong repolarization,widening the QRS and prolonging the QT interval.ADecrease automaticity and conduction and prolong refractoriness.Antiarrhythmia drugCl
25、ass IV agents -slow calcium channel blockers Decrease automaticity andAtrioventricular conduction DrugsWilliamsWilliams分类法:分类法:I:II:III:IV:A:QuinidineC:FlecainidePropranololAmiodaroneVerapamil ProcainamideEncainideMetoprololSotalolDiltiazem ChangrolinPropafenoneEsmololBretyliumBepridilB:Lidocaine At
展开阅读全文